Finance News
$MATH Metalpha Technology Authorizes a $5 Million Share Repurchase Program
$NRXP given a $31 Price Target from Respected Investment Analyst D. Boral Capital
$NRXP New Drug Application for Treatment of Suicidal Depression. Completion of NDA Filing Expected in First Quarter of 2025
NRx Pharmaceuticals, Inc.: Stock Symbol: NRXP IS Aiming to be the First FDA-Approved Medication to Treat Suicidal Depression
$NRXP: Completion of NDA Filing Expected in First Quarter of 2025
$RENB is working with large $NVDA partner Nebul developing AI and Biotechnology Platforms for Early Diagnosis, Better-Targeted Treatments and Drug Discovery
$TKMO clients Include: Walmart $WMT, Target $TGT, Costco $COST, Office Depot $ODP, GameStop $GME and many more.